発表論文 (Recent)

Update 20-APR-2019

*Corresponding author

2019

  1. Mana InadaMika ShindoKyousuke Kobayashi, *Akira Sato, Yohei Yamamoto,  Yasuharu Akasaki, Koichi Ichimura, *Sei-ichi Tanuma. Anticancer effects of a non-narcotic opium alkaloid medicine papaverine in human glioblastoma cells. PLOS ONE, in press. (IF=2.766, CiteScore=3.01 in 2017)
  2. Yoko Ogino, Akira Sato, Fumiaki Uchiumi, Sei-ichi Tanuma. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells. Genomics, in press. (IF=3.270 in 5-Year, IF=2.91 in 2017, CiteScore=2.97 in 2017)
  3. Kenya Tamada, Shingo Nakajima, Natsumi Ogawa, Mana Inada, Hiroyuki Shibasaki, Akira Sato, Ryoko Takasawa, Atsushi Yoshimori, Yusuke Suzuki, Nobuo Watanabe, Takahiro Oyama, Hideaki Abe, Shigeaki, Inoue, Takehiko Abe, Takehiko Yokomizo, *Sei-ichi Tanuma. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses. Biochemical and Biophysical Research Communications, 511(3), 665-670, 2019. doi: 10.1016/j.bbrc.2019.01.136 (IF=2.455 in 5-Year, IF=2.559 in 2017, CiteScore=2.62 in 2017)
  4. Hitoshi Tsugawa, Hideki Mori, Juntaro Matsuzaki, Akira Sato, Yoshimasa Saito, Masayo Imoto, Makoto Suematsu, *Hidekazu Suzuki. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy. Autophagy, 15(2), 242-258, 2019. doi:10.1080/15548627.2018.1515530. (IF=11.100 in 2017, CiteScore=7.07 in 2017)

 

search previous next tag category expand menu location phone mail time cart zoom edit close